[MRCB] YoY Cumulative Quarter Result on 31-Dec-2014 [#4]

Stock
[MRCB] MALAYSIAN RESOURCES CORPORATION BERHAD
Announcement Date
23-Feb-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
31-Dec-2014 [#4]
Profit Trend
QoQ- -3.34%
YoY- 239.86%
Quarter Report
Latest QR
Upcoming QR
MRCB's Result
MRCB's Financial Summary
View:
Show?
Cumulative Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 2,823,651 2,408,072 1,696,727 1,514,767 940,910 1,283,204 1,226,705 14.89%
PBT 247,333 392,629 370,112 220,618 -110,367 134,002 123,313 12.28%
Tax -65,525 -73,532 -6,083 -37,099 -7,584 -42,835 -15,326 27.36%
NP 181,808 319,097 364,029 183,519 -117,951 91,167 107,987 9.06%
-
NP to SH 167,575 267,360 330,392 152,634 -109,132 60,122 93,524 10.19%
-
Tax Rate 26.49% 18.73% 1.64% 16.82% - 31.97% 12.43% -
Total Cost 2,641,843 2,088,975 1,332,698 1,331,248 1,058,861 1,192,037 1,118,718 15.38%
-
Net Worth 2,411,814 2,644,539 2,259,166 1,928,008 1,500,934 1,415,776 1,376,024 9.79%
Dividend
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Div 38,369 53,278 44,647 42,730 14,787 27,705 27,714 5.56%
Div Payout % 22.90% 19.93% 13.51% 28.00% 0.00% 46.08% 29.63% -
Equity
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Net Worth 2,411,814 2,644,539 2,259,166 1,928,008 1,500,934 1,415,776 1,376,024 9.79%
NOSH 4,386,746 1,937,391 1,785,902 1,709,227 1,478,753 1,385,299 1,385,724 21.15%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin 6.44% 13.25% 21.45% 12.12% -12.54% 7.10% 8.80% -
ROE 6.95% 10.11% 14.62% 7.92% -7.27% 4.25% 6.80% -
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
RPS 128.78 124.29 95.01 88.62 63.63 92.63 88.52 6.44%
EPS 6.56 13.80 18.50 8.93 -7.38 4.34 6.75 -0.47%
DPS 1.75 2.75 2.50 2.50 1.00 2.00 2.00 -2.19%
NAPS 1.10 1.365 1.265 1.128 1.015 1.022 0.993 1.71%
Adjusted Per Share Value based on latest NOSH - 1,758,333
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
RPS 63.75 54.36 38.31 34.20 21.24 28.97 27.69 14.89%
EPS 3.78 6.04 7.46 3.45 -2.46 1.36 2.11 10.19%
DPS 0.87 1.20 1.01 0.96 0.33 0.63 0.63 5.52%
NAPS 0.5445 0.597 0.51 0.4353 0.3388 0.3196 0.3107 9.79%
Price Multiplier on Financial Quarter End Date
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Date 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 -
Price 1.12 1.33 1.28 1.22 1.29 1.55 2.16 -
P/RPS 0.87 1.07 1.35 1.38 2.03 1.67 2.44 -15.77%
P/EPS 14.65 9.64 6.92 13.66 -17.48 35.71 32.00 -12.19%
EY 6.82 10.38 14.45 7.32 -5.72 2.80 3.12 13.90%
DY 1.56 2.07 1.95 2.05 0.78 1.29 0.93 8.99%
P/NAPS 1.02 0.97 1.01 1.08 1.27 1.52 2.18 -11.88%
Price Multiplier on Announcement Date
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Date 28/02/18 27/02/17 22/02/16 23/02/15 25/02/14 26/02/13 08/02/12 -
Price 1.08 1.43 1.21 1.40 1.57 1.27 2.24 -
P/RPS 0.84 1.15 1.27 1.58 2.47 1.37 2.53 -16.77%
P/EPS 14.13 10.36 6.54 15.68 -21.27 29.26 33.19 -13.25%
EY 7.08 9.65 15.29 6.38 -4.70 3.42 3.01 15.30%
DY 1.62 1.92 2.07 1.79 0.64 1.57 0.89 10.48%
P/NAPS 0.98 1.05 0.96 1.24 1.55 1.24 2.26 -12.98%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment